USANA Health Sciences stock costs EUR 13.20 ahead of results

Published on 10/05/2026 at 16:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue fell 5.30 percent to USD 223.30 million in the second quarter. USANA Health Sciences stock was EUR 13.20 on October 5, 2026.

USNA, US90328M1071, Illustration mit AI erstellt.

USANA Health Sciences (ISIN US90328M1071) was trading at EUR 13.20 at Lang & Schwarz on October 5, 2026 at 4:33 p.m. CEST, unchanged from the prior close. The next measurable test arrives with the company's scheduled third-quarter results on October 28, 2026, according to MarketBeat.

Second-quarter loss changes the baseline

USANA's latest reported quarter ended July 4, 2026. The company reported second-quarter net sales of USD 223.0 million and diluted earnings per share of minus USD 1.16, according to USANA Health Sciences.

The comparison is the sharper signal. Simply Wall St reported that second-quarter revenue declined 5.30 percent from the prior-year quarter, while earnings per share moved from a USD 0.52 profit to a USD 1.16 loss. That shift puts operating execution ahead of product headlines for the next results cycle.

October results carry the next comparison

USANA develops and sells nutrition, personal care and wellness products through an international direct-selling model, with the company identifying NYSE: USNA on its investor-relations page. Its second-quarter operating cash flow was USD 23.3 million, giving the upcoming report a second lens beyond sales and earnings.

MarketBeat lists expected third-quarter revenue of USD 219.02 million and consensus earnings per share of USD 0.11 for the October 28, 2026 report. Those figures are estimates, not reported results, but they establish the numerical bar for the next update and make the prior-year comparison easier to judge.

USNA stock price stays flat

USANA Health Sciences stock was trading at EUR 13.20 at Lang & Schwarz on October 5, 2026 at 4:33 p.m. CEST. The price was unchanged at 0.00 percent versus the Lang & Schwarz prior close of EUR 13.20 from October 2, 2026, while the primary-exchange quote was USD 14.68 at the NYSE on October 5, 2026 at 10:39 a.m. ET.